US Patent Issued to Institute of Biophysics, Chinese Academy of Sciences on May 12 for "Use of the active compound in the prevention or treatment of ovarian dysfunction diseases" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,890, issued on May 12, was assigned to Institute of Biophysics, Chinese Academy of Sciences (Beijing).

"Use of the active compound in the prevention or treatment of ovarian dysfunction diseases" was invented by Cuiling Lu (Beijing), Tao Jiang (Beijing) and Yanxiao Yi (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of the active compound in the present disclosure for the prevention or treatment of ovarian dysfunction disease. In particular, the present disclosure relates to the use of a compound shown in Formula I or a pharmaceutically acceptable salt thereof in the treatment or prevention of ovarian dysfunction disease, wherein R1 and R2 ...